908 Devices Stock

908devices.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $74MM

908 Devices is the designer and manufacturer of point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices.

Register for Details

For more details on financing and valuation for 908 Devices, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for 908 Devices.

Register Today

Team

Management Team

Joseph Griffith
Chief Financial Officer
Scott Miller Ph.D
Co-Founder & Director, Mass Spectrometer Engineering
Christopher Brown
Co-Founder, Chief Technology Officer & Vice President
Michael Jobin
Co-Founder & Director Product Development
Kevin Knopp Ph.D
Co-Founder, Chief Executive Officer, President & Board Member
Andy Bartfay
Co-Founder & Director of Hardware Development
Steve Araiza
Co-Founder and Director of Software

Board Members

Keith Crandell
ARCH Venture Partners
Sharon Kedar
Northpond Ventures
J. Michael Ramsey Ph.D
Nicolas Barthelemy
Kevin Hrusovsky
Mark Spoto JD
Razor's Edge Ventures

Other companies like 908 Devices in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

908 Devices Prices $100M Public Offering
The company priced a public offering of 3,150,000 shares of its common stock at $32.00 per share that is expected to gross approximately $100.8 million.
Updated on: Sep 21, 2023